8-K

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                               ------------------

                                    FORM 8-K

                                 Current Report
                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934


         Date of report (Date of earliest event reported): July 20, 2004

                                RAMP CORPORATION
             (Exact Name of Registrant as Specified in Its Charter)

          DELAWARE                      0-24768                  84-1123311
- ----------------------------          ------------          -------------------
(State or Other Jurisdiction          (Commission             (I.R.S. Employer
     of Incorporation)                File Number)          Identification No.)


     33 Maiden Lane, New York, NY                                 10038
- --------------------------------------------------------------------------------
(Address of Principal Executive Offices)                        (Zip Code)


                                 (212) 440-1500
       ------------------------------------------------------------------
              (Registrant's Telephone Number, Including Area Code)



     -----------------------------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)







Item 5.  Other Events and Regulation FD Disclosure.

         On July 20, 2004, Ramp Corporation (the "Company") issued a press
release announcing that it's wholly owned subsidiary HealthRamp has verified
better than expected preliminary results from its U.S. electronic prescribing
pilot project with Celltech Pharmaceuticals, Inc. A copy of that press release
is attached to this Form 8-K as Exhibit 99.1


                               S I G N A T U R E
                               -----------------


         Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.



                                                     RAMP CORPORATION


                                            By:    /s/ Andrew Brown
                                                   -----------------------------
Date: July 20, 2004                         Name:  Andrew Brown
                                            Title: Chief Executive Officer and
                                                   President







                                  EXHIBIT INDEX

Exhibit
Number          Description
- ------          -----------
99.1            Press release of the Company dated July 20, 2004.

EX-99

                                                                    Exhibit 99.1


FOR IMMEDIATE RELEASE                                Contact: Andrew Brown

July 20, 2004                                        212-440-1548



     HealthRamp and Celltech Pharmaceuticals Announce Interim Pilot Findings

     Intelligent Messaging at the Point-of-Care has Tripled Market Share for

   Celltech's Once-daily Metadate(R) CD ADHD Treatment Among Pilot Physicians


         New York, NY - Ramp Corporation [AMEX: RCO] today announced that it's
wholly owned subsidiary HealthRamp has verified better than expected preliminary
results from its U.S. electronic prescribing pilot project with Celltech
Pharmaceuticals, Inc. Celltech is one of Europe's largest biotechnology
companies, with an innovative development pipeline and a cash-generative
pharmaceutical business. Ramp, through its wholly owned HealthRamp subsidiary,
markets the CarePoint and CareGiver technology suites. CarePoint enables
electronic prescribing, lab orders and results, Internet-based communication,
data integration, and transaction processing over a handheld device or browser,
at the point-of-care.

         The Celltech pilot showcases HealthRamp's patent pending intelligent
messaging technology which analyzes patient attributes, proposed treatments and
partner relationships so that alternative medications can be suggested in a
manner absent of undue influence on the physician and the prescribing process.
One challenge is that the pilot group of physicians, which is comprised mainly
of psychiatrists who treat ADHD, do not fit the profile of healthcare
professionals who might readily adopt an electronic prescribing product. Initial
pilot findings over a 6-month period show more than a 200% increase in Metadate
CD prescriptions and an electronic prescribing adoption rate of over 85%.

         Dan Greenleaf, President - Celltech Pharmaceuticals, Inc., commented,
"The initial findings from our electronic prescribing pilot with HealthRamp are
very encouraging. Providing intelligent

         FDA-approved messages and other information at the point of prescribing
appears to be an effective means to make physicians aware of our product
benefits and target our competition on a large scale. I am impressed with
HealthRamp's ability to overcome the issues seen with other electronic
prescribing initiatives. I am optimistic that the final pilot results will
demonstrate a substantial incremental return that would support employing
HealthRamp's products and services as mainstream sales tools."

         "My time is too valuable to pay attention to sales rhetoric and search
for the New York



State triplicate prescription pad. My thriving practice requires me to spend
time caring for my patients," stated Robert M. Trepel, M.D. "Celltech and
HealthRamp have been sensitive to my needs. HealthRamp CarePoint(TM) allows me
to prescribe anywhere in a safe and efficient fashion, while the Celltech
messages I choose to observe have been informative, high-minded and discreet."

         "Celltech's vision, expertise and diligence have made them the perfect
partner for this pilot. The pilot's exceedingly positive preliminary results are
attributable to the collaborative learning, analysis and execution exhibited by
our two companies over the past nine months," stated Andrew Brown, Ramp CEO and
President. "This pilot indicates that we are well-positioned to offer a proven
electronic prescribing and detailing solution to prospective healthcare industry
partners, including pharmaceutical companies, health plans and pharmacy benefit
managers. Ultimately, intelligent messaging at the point-of-care should allow
companies outside of healthcare to benefit from this effective means of
communicating with physicians as well. Interactions with the physician, in a
benign, informative manner, are one of the keys to our long-term revenue model,
making the Celltech pilot findings even more encouraging," concluded Brown.

         Celltech Pharmaceuticals, Inc. is the U.S. subsidiary of Celltech Group
plc [LSE: CCH; NYSE: CLL], one of Europe's largest biotechnology companies, with
an innovative development pipeline and a cash-generative pharmaceutical
business. Celltech also possesses drug discovery capabilities of exceptional
strength, including a leading position in antibody engineering.

         Ramp Corporation, through its wholly owned HealthRamp subsidiary,
markets the CareGiver and CarePoint technology suites. CarePoint enables
electronic prescribing, lab orders and results, Internet-based communication,
data integration, and transaction processing over a handheld device or browser,
at the point-of-care. CareGiver allows long term care facility staff to easily
place orders for drugs, treatments and supplies from a wireless handheld PDA or
desktop Internet web browser. HealthRamp's products enable communication of high
value-added healthcare information among physician offices, pharmacies,
hospitals, pharmacy benefit managers, health management organizations,
pharmaceutical companies and health insurance companies. Ramp's OnRamp division
provides a state of the art telecommunications center that enables 24/7
communication between a medical practice and its patients. Additional
information about Ramp, and its products and services, can be found at
www.Ramp.com.

         Safe Harbor Statement: To the extent that any statements made in this
press release contain information that is not historical, these statements are
essentially forward-looking. Forward-looking statements can be identified by the
use of words such as "expects," "plans," "will," "may," "anticipates,"
"believes," "should," "intends," "estimates," and other words of similar
meaning. These statements are subject to risks and uncertainties that cannot be
predicted or quantified and, consequently, actual results may differ materially
from those expressed or implied by such forward-looking statements. Such risks
and uncertainties include, without limitation, the ability of the Company to
raise capital to finance the development of its Internet services and related
software, the effectiveness, profitability and the marketability of those
services, the ability of the Company to protect its proprietary information and
to retain and expand its user base, the establishment of an efficient corporate
operating structure as the



Company grows and, other risks detailed from time-to-time in our filings with
the Securities and Exchange Commission. The Company undertakes no obligation to
publicly update any forward-looking statements.